Atlas Trials

Clavulanic Acid for the Treatment of Cocaine Use Disorder

Clinical trial NCT05562349 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05562349
Sponsor
Temple University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Cocaine Dependence
Start date
2023-05-03
Primary completion
2024-07-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.